Nine years after selling Medivation to Pfizer for $14 billion, David Hung, M.D., is going toe to toe with the New York drugmaker and two other pharma giants in a lung cancer field. More: David Hung's Nuvation Bio wins FDA
read moreGenentech is letting go of 143 employees who are based out of the company’s headquarters in South San Francisco. More: Genentech lays off 143 workers at South San Francisco campus Source: fierce
read moreWhile the race is on to develop antibody-drug conjugate cancer treatments, so too is the competition to manufacture them. Hoping to gain an edge in the rapidly growing market are MilliporeSigma and Simtra BioPharma Solutions, which have forged a five-year
read moreThe Food and Drug Administration has gone all in on AI since Martin Makary, M.D., took over the agency, most recently demonstrated by the coronation of new generative AI tool Elsa. Now, Makary and Vinay Prasad, M.D., director of the
read moreDespite an outcry from the biopharmaceutical industry, the U.K. government has kept the rebate rate under a national drug-cost scheme at a higher level compared with previous years. More: Pharmas to face higher drug rebates in UK despite government's tweak
read more
Three-year data highlights inflammation control in psoriatic arthritis More: Bimekizumab shows lasting efficacy at EULAR 2025 Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals